PL370294A1 - Sposób ekstrakcji, oczyszczania i enzymatycznej modyfikacji podjednostki 7s sojowej globuliny alfa'do zastosowania jako środek obniżający poziom cholesterolu - Google Patents

Sposób ekstrakcji, oczyszczania i enzymatycznej modyfikacji podjednostki 7s sojowej globuliny alfa'do zastosowania jako środek obniżający poziom cholesterolu

Info

Publication number
PL370294A1
PL370294A1 PL03370294A PL37029403A PL370294A1 PL 370294 A1 PL370294 A1 PL 370294A1 PL 03370294 A PL03370294 A PL 03370294A PL 37029403 A PL37029403 A PL 37029403A PL 370294 A1 PL370294 A1 PL 370294A1
Authority
PL
Poland
Prior art keywords
subunit
soy
extraction
hypocholesterolemizing
purification
Prior art date
Application number
PL03370294A
Other languages
English (en)
Other versions
PL209342B1 (pl
Inventor
Marcello Duranti
Paolo Morazzoni
Original Assignee
Indena S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena S.P.A. filed Critical Indena S.P.A.
Publication of PL370294A1 publication Critical patent/PL370294A1/pl
Publication of PL209342B1 publication Critical patent/PL209342B1/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/14Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from leguminous or other vegetable seeds; from press-cake or oil-bearing seeds
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00Working-up of proteins for foodstuffs
    • A23J3/14Vegetable proteins
    • A23J3/16Vegetable proteins from soybean
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/185Vegetable proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/02Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/04Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
    • C12P7/06Ethanol, i.e. non-beverage
    • CCHEMISTRY; METALLURGY
    • C13SUGAR INDUSTRY
    • C13KSACCHARIDES OBTAINED FROM NATURAL SOURCES OR BY HYDROLYSIS OF NATURALLY OCCURRING DISACCHARIDES, OLIGOSACCHARIDES OR POLYSACCHARIDES
    • C13K1/00Glucose; Glucose-containing syrups
    • C13K1/06Glucose; Glucose-containing syrups obtained by saccharification of starch or raw materials containing starch
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00Technologies for the production of fuel of non-fossil origin
    • Y02E50/10Biofuels, e.g. bio-diesel

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
PL370294A 2002-01-29 2003-01-27 Sposób selektywnej ekstrakcji, oczyszczania i enzymatycznej modyfikacji podjednostki α' sojowej β-konglicyniny, jej fragmenty polipeptydowe i ich zastosowanie oraz kompozycje farmaceutyczne, dodatki lub produkty spożywcze zawierające te fragmenty polipeptydowe PL209342B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002MI000147A ITMI20020147A1 (it) 2002-01-29 2002-01-29 Estrazione purificazione e modificazione di polipeptidi da seme di soia

Publications (2)

Publication Number Publication Date
PL370294A1 true PL370294A1 (pl) 2005-05-16
PL209342B1 PL209342B1 (pl) 2011-08-31

Family

ID=11449014

Family Applications (1)

Application Number Title Priority Date Filing Date
PL370294A PL209342B1 (pl) 2002-01-29 2003-01-27 Sposób selektywnej ekstrakcji, oczyszczania i enzymatycznej modyfikacji podjednostki α' sojowej β-konglicyniny, jej fragmenty polipeptydowe i ich zastosowanie oraz kompozycje farmaceutyczne, dodatki lub produkty spożywcze zawierające te fragmenty polipeptydowe

Country Status (20)

Country Link
US (3) US7465467B2 (pl)
EP (1) EP1469741B1 (pl)
JP (1) JP4522706B2 (pl)
KR (1) KR100991641B1 (pl)
CN (1) CN100558243C (pl)
AT (1) ATE341943T1 (pl)
AU (1) AU2003208346B8 (pl)
CA (1) CA2474106C (pl)
CY (1) CY1107514T1 (pl)
DE (1) DE60308994T2 (pl)
DK (1) DK1469741T3 (pl)
ES (1) ES2274208T3 (pl)
IL (1) IL163225A (pl)
IT (1) ITMI20020147A1 (pl)
NO (1) NO327156B1 (pl)
PL (1) PL209342B1 (pl)
PT (1) PT1469741E (pl)
RU (1) RU2300898C2 (pl)
SG (1) SG152048A1 (pl)
WO (1) WO2003063608A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6171640B1 (en) * 1997-04-04 2001-01-09 Monsanto Company High beta-conglycinin products and their use
KR100991588B1 (ko) * 2002-11-12 2010-11-04 후지 세이유 가부시키가이샤 분획된 대두 단백질 및 그 제조방법
JP4687463B2 (ja) * 2003-12-11 2011-05-25 不二製油株式会社 改良大豆7sたん白及びその製造法
JP5382840B2 (ja) * 2005-08-23 2014-01-08 特定非営利活動法人プライメイト・アゴラ サルモデルで薬効が確認された骨粗鬆症の予防又は治療剤
WO2010078462A1 (en) * 2008-12-31 2010-07-08 Solae, Llc Protein hydrolysate compositions
EP2264054A1 (en) * 2009-06-17 2010-12-22 Indena S.p.A. Cloning, yeast expression, purification and biological activity of a truncated form of the soybean 7S globulin alfa ' subunit involved in Hep G2 cell cholesterol homeostasis
SI2264055T1 (sl) * 2009-06-17 2014-05-30 Indena S.P.A. Kloniranje, izraĺ˝anje v kvasovki, äśiĺ äśenje in bioloĺ ka aktivnost ekstenzijske regije alfa'podenote sojinega 7s globulina udeleĺ˝ene pri homeostazi holesterola hepg2 celice
CN101904406B (zh) * 2010-07-02 2012-07-25 山西大学 一种葵花籽多肽的制备方法和用途
CN104163767B (zh) * 2014-07-25 2017-01-18 湖北泓肽生物科技有限公司 一种氨基酸和多肽水溶性物质的纯化方法
CN114874301A (zh) * 2022-05-10 2022-08-09 吉林农业大学 不同亚基组成β-伴大豆球蛋白的制备方法及应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4409248A (en) * 1981-08-10 1983-10-11 A. E. Staley Manufacturing Company Heat-gelling and foam-stabilizing enzymatically modified vegetable isolates
JPH06197788A (ja) 1993-01-06 1994-07-19 Fuji Oil Co Ltd 蛋白質の製造法
ES2139420T3 (es) * 1996-03-28 2000-02-01 Fuji Oil Co Ltd Un procedimiento para producir un hidrolizado de proteina de soja.
JP3928811B2 (ja) * 1996-06-14 2007-06-13 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー 特定のクラスのダイズ種子タンパク質遺伝子の抑制
US6171640B1 (en) * 1997-04-04 2001-01-09 Monsanto Company High beta-conglycinin products and their use
US6365802B2 (en) * 1998-08-14 2002-04-02 Calgene Llc Methods for increasing stearate content in soybean oil
FR2784029B1 (fr) 1998-10-05 2001-01-05 Pharmascience Lab Methode de prevention et/ou de traitement cosmetique des vergetures de la peau et utilisation en dermatologie
WO2000063389A1 (en) * 1999-04-15 2000-10-26 Calgene Llc Nucleic acid sequences to proteins involved in isoprenoid synthesis
CA2274414A1 (en) 1999-06-11 2000-12-11 Universite Laval Dietary fish protein for use in restoring normal insulin function insulin-resistant individuals
AUPQ877300A0 (en) * 2000-07-13 2000-08-03 Johnson & Johnson Pacific Pty Limited Topical treatment of skin
NZ536466A (en) * 2002-04-18 2008-04-30 Monsanto Technology Llc Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease
CA2477922C (en) * 2003-08-20 2010-10-26 Seikagaku Corporation Stabilizing agent for enzymes
MX2007008496A (es) * 2005-01-14 2007-09-14 Solae Llc Proteina de soya para formula infantil.

Also Published As

Publication number Publication date
EP1469741B1 (en) 2006-10-11
DK1469741T3 (da) 2007-02-19
WO2003063608A1 (en) 2003-08-07
US7901718B2 (en) 2011-03-08
NO327156B1 (no) 2009-05-04
US8257758B2 (en) 2012-09-04
CY1107514T1 (el) 2013-03-13
AU2003208346B2 (en) 2008-03-06
AU2003208346B8 (en) 2008-07-10
ATE341943T1 (de) 2006-11-15
DE60308994T2 (de) 2007-06-14
ITMI20020147A1 (it) 2003-07-29
DE60308994D1 (de) 2006-11-23
JP2005516043A (ja) 2005-06-02
CN1622760A (zh) 2005-06-01
RU2004123201A (ru) 2005-10-27
AU2003208346A2 (en) 2003-09-02
CA2474106A1 (en) 2003-08-07
KR20040077786A (ko) 2004-09-06
RU2300898C2 (ru) 2007-06-20
CA2474106C (en) 2011-11-22
US20110118182A1 (en) 2011-05-19
NO20043186L (no) 2004-07-26
PT1469741E (pt) 2007-01-31
US20080261885A1 (en) 2008-10-23
ITMI20020147A0 (it) 2002-01-29
CN100558243C (zh) 2009-11-11
ES2274208T3 (es) 2007-05-16
HK1073590A1 (zh) 2005-10-14
IL163225A (en) 2007-06-17
US7465467B2 (en) 2008-12-16
JP4522706B2 (ja) 2010-08-11
EP1469741A1 (en) 2004-10-27
US20050164337A1 (en) 2005-07-28
KR100991641B1 (ko) 2010-11-04
PL209342B1 (pl) 2011-08-31
SG152048A1 (en) 2009-05-29

Similar Documents

Publication Publication Date Title
PL370294A1 (pl) Sposób ekstrakcji, oczyszczania i enzymatycznej modyfikacji podjednostki 7s sojowej globuliny alfa'do zastosowania jako środek obniżający poziom cholesterolu
ATE386110T1 (de) Prolylendoprotease aus aspergillus niger
DE60124918D1 (de) Kodon-optimierte papillomavirussequenzen
BR0012212A (pt) Processo de hidrogenação de 3-hidroxipropanal em 1,3-propanodiol, processo de preparação de 1,3-propanodiol, processo de purificação de uma solução aquosa de 3-hidroxipropanal e composição de 1,3-propanodiol
ES2139420T3 (es) Un procedimiento para producir un hidrolizado de proteina de soja.
ATE317898T1 (de) Rekombinante terminale deoxynukleotidyltransferase mit verbesserter funktionalität
BG103694A (en) Improved method for the preparation and purification of n-alkylated asparginic derivative
DE60027406D1 (de) Rückgewinnung eines proteins bei hohem ph-wert
BR9809292A (pt) Métodos aperfeiçoados para o processamento de proteìna c ativada
MY152824A (en) Combination of hcv ns3 protease inhibitor with interferon and ribavirin.
PT912197E (pt) Conjugados de hemoglobina-hidroxietilamido como veiculos de oxigenio
DE60228847D1 (pl)
JP2005516043A5 (pl)
DK1339735T3 (da) Fremgangsmåde til fremstilling af tryptophanrige peptider
MX2009007047A (es) Mejorador de sabor de hidrolizado de proteina bajo en sodio y elevado en calcio y un metodo para preparar el mismo.
WO2004043373A3 (en) Precursor n-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme
NZ541231A (en) A method of treatment or prophylaxis of symptoms of herpes viral infection
WO2003084908A3 (en) Preventing undesired odor in and/or purifying alkanediols
TW200517368A (en) Process
du Vigneaud The role which insulin has played in our concept of protein hormones, and a consideration of certain phases of the chemistry of insulin
SE0203551D0 (sv) Prothrombin purification
ITMI20022409A1 (it) Procedimento per la purificazione di 1, 4-butandiolo mononitrato.
NO984365D0 (no) IgAl proteasefragment som bµrerpeptid
BRPI0502744A (pt) processo para reduzir a atividade do ativador de pré-calicreìna (pka) em soluções de albumina purificada de origem humana e para estabilizá-la temporalmente; processo para obter albumina; e solução purificada de albumina de origem humana com baixa atividade do ativador de pré-calicreìna (pka) e com estabilidade temporal
SI1469741T1 (sl) Postopek za ekstrakcijo, ciscenje in encimsko modifikacijo alfa'podenote sojinega 7s-globulina za uporabo kot hipoholesterolemicno sredstvo